Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Oral administration of berberine limits post-traumatic osteoarthritis development and associated pain via AMP-activated protein kinase (AMPK) in mice

Osteoarthritis and Cartilage(2021)10.1016/j.joca.2021.10.004Source: DataRank Database

Oral administration of berberine limits post-traumatic osteoarthritis development and associated pain via AMP-activated protein kinase (AMPK) in mice is a research paper published in Osteoarthritis and Cartilage (2021). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.94)OA: greenTopics (47)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Yun Wang ORCID,Di Chen ORCID,Ru Liu‐Bryan ORCID,J Li ORCID

Live enrichment

PubMed:34687898 PMC:PMC8712393 OpenAlex:https://openalex.org/W3205652832

National Institutes of Health

Grant: R01AR070222

U.S. Department of Veterans Affairs

Grant: 1I01BX002234

BLRD VA

Grant: I01 BX002234

National Institutes of Health

Grant: 5I01BX002234-03

AMPK as an Interventional Target to Suppress the Development of Osteoarthritis

National Institutes of Health

Grant: 5R01AR070222-03

The Role of MicroRNA in Osteoarthritis

FWCI

5.94

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8712393

publisherhttps://api.elsevier.com/content/article/PII:S1063458421009353?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1063458421009353?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.joca.2021.10.004

Fields of Study

Berberine and alkaloids researchAutophagy in Disease and TherapySphingolipid Metabolism and Signaling0301 basic medicine0303 health sciences03 medical and health sciencesAMP-Activated Protein KinasesAdministration, OralAnimalsArthralgiaBerberineJointsMaleMiceOsteoarthritis

MeSH Terms

Administration, OralAnimalsBerberineJointsMaleOsteoarthritisArthralgiaMiceAMP-Activated Protein Kinases

Keywords

BerberineAMPKProtein kinase AAMP-activated protein kinaseOsteoarthritisMedicinePhosphorylationEndocrinologyInternal medicineCartilagePharmacologyChemistryPathologyBiochemistryAnatomyPainMaleMiceAdministration, OralAnimalsJointsAMP-Activated Protein KinasesArthralgia

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Clean water and sanitation

Additional file 1 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733873.v1figshare

Additional file 1 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733873figshare

Additional file 2 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733876.v1figshare

Additional file 2 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733876figshare

Additional file 3 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733879.v1figshare

Additional file 3 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733879figshare

Additional file 4 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733882.v1figshare

Additional file 4 of α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway

10.6084/m9.figshare.26733882figshare